Searched for
INDIA COVID CARE
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- Bengaluru techie reveals why she left Rs 30 LPA job at 30, to pursue a different career: ‘My body gave up….’A 30-year-old Bengaluru tech professional, Aakriti Goel, left a lucrative Rs 30 lakh per annum job at Healofy to pursue her lifelong dream ...
- IITian grew up in one bedroom home, had no stable income for 6 years after graduation. An advice from his mother transformed his businessAn IIT BHU graduate, Saurabh Bothra, defied expectations by leaving a stable career path to pursue yoga. After facing financial uncertainty...
- Manu Chandra's Sauce, the VC making a feast of small servingsSauce VC is set to make an estimated Rs 500-550 crore from L'Oréal's acquisition of Innovist, validating founder Manu Chandra's strategy of...
- RBI MPC minutes: Policy misstep fears drove rate pause amid West Asia uncertaintyThe Reserve Bank of India's Monetary Policy Committee has opted for a cautious "wait and watch" stance, holding the repo rate steady due to...
- L’Oréal adds Innovist to cart; HealthQuad's new fundHappy Friday! Personal care giant L’Oreal has acquired a majority stake in Innovist in India’s biggest D2C deal. This and more in today’s E...
- Pet care firm Vetic raises $40 million led by Bessemer Venture PartnersVetic, a pet care startup, has secured $40 million in funding. This investment will fuel the expansion of its clinic network, adding 25 new...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- War and AI force India Inc to rethink huge office dealsLarge office leasing deals in India are experiencing extended closing times as companies adopt a cautious approach to expansion amid geopol...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- India's healthcare transformed in 12 years under PM Modi: ReportIndia's healthcare sector has seen a major transformation over the last 12 years. Health insurance coverage has expanded significantly. Mat...
- Tourism and hotel sector stocks: Time for a correction in business? Are analysts getting it wrong? 15 stocks from the ecosystemThe Indian hotel and tourism ecosystem has benefitted from the post-Covid travel urge. Occupancies were high, room rates firm, supply is, i...
- 100 days of Iran war: India must brace for broad-based economic shockIn a volatile turn of events, escalating strikes between Iran and Israel are sending shockwaves that may reach India’s economy. As the spec...
- ET Alpha Wealth Summit: S Naren shares blueprint for investing in a boring marketICICI Prudential AMC CIO S. Naren described the current market as a “boring phase,” marked by a tug-of-war between FIIs and domestic mutual...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Volatility as opportunity, depends on framework of mind: 5 mid-caps from different sectors with upside potential of up to 31%The Indian stock market is no longer correcting only because of sentiment. It is now adjusting to the possibility of weaker numbers in the ...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- From $22 billion to zero: Success, not failure, brought Byju downByju's, once a $22 billion edtech giant, has collapsed. Founder Byju Raveendran faces jail for contempt. The company's downfall stems from ...
- Covid is now hitting young Indians in a shocking new way, doctors say people in their 30s are suddenly needing hip replacementsHip replacement surgeries among Indians in their 30s and 40s have reportedly risen by nearly 40 per cent in the post-Covid period. Doctors ...
Load More
